FDA inspection
Mark L. Brantly, M.D.: FDA inspection ending Apr 14, 2017
FDA inspection 1012256 · No Action Indicated (NAI) · Gainesville, FL
Key facts
| Inspection ID | 1012256 |
|---|---|
| Firm | Mark L. Brantly, M.D. |
| FEI number | 3003556276 |
| Address | University of Florida School of Medicine, 1600 SW Archer Rd |
| City | Gainesville |
| State | FL |
| ZIP | 32610 |
| Country | United States |
| Fiscal year | 2017 |
| Inspection end date | Apr 14, 2017 |
| Classification | No Action Indicated (NAI) |
| Project area | Bioresearch Monitoring |
| Product type | Biologics |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data